Aurora Cannabis - Common Shares (ACB) closed at $3.96 on October 21, 2026, down 0.3% from the previous close, on volume of 781,905 shares (30-day average 972,499).
Data as of October 21, 2026.
21-Oct-2026
M&A News: Canada’s Aurora Cannabis (ACB) Rejects Sweetened Takeover Offer
TipRanks (Mon, 19-Oct 5:51 PM ET)
PRNewswire (Wed, 14-Oct 3:51 PM ET)
PRNewswire (Thu, 8-Oct 7:05 AM ET)
PRNewswire (Tue, 6-Oct 4:31 PM ET)
PRNewswire (Mon, 5-Oct 6:12 PM ET)
PRNewswire (Wed, 23-Sep 6:28 PM ET)
PRNewswire (Wed, 16-Sep 7:05 AM ET)
Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts
PRNewswire (Mon, 14-Sep 2:13 PM ET)
PRNewswire (Wed, 9-Sep 7:05 AM ET)
PRNewswire (Wed, 2-Sep 11:18 AM ET)
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
Aurora Cannabis - Common Shares trades on the NASDAQ stock market under the symbol ACB.
As of October 21, 2026, ACB stock price declined to $3.96 with 781,905 million shares trading.
ACB has a beta of 1.46, meaning it tends to be more sensitive to market movements. ACB has a correlation of 0.12 to the broad based SPY ETF.
ACB has a market cap of $245.29 million. This is considered a Small Cap stock.
Last quarter Aurora Cannabis - Common Shares reported $49 million in Revenue and -$.05 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.08.
In the last 3 years, ACB traded as high as $9.35 and as low as $2.56.
The top ETF exchange traded funds that ACB belongs to (by Net Assets): MJ, YOLO, DFIC.
ACB has underperformed the market in the last year with a price return of -25.7% while the SPY ETF gained +16.3%. However, in the short term, ACB had mixed performance relative to the market. It has outperformed in the last 3 months, returning +52.9% vs +4.4% return in SPY. But in the last 2 weeks, ACB shares have been beat by the market, returning -13.7% compared to an SPY return of -0.8%.
ACB support price is $3.86 and resistance is $4.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACB shares will trade within this expected range on the day.
